AsymBio, a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group, has secured a total capital...
-
-
Recent Updates
- KraneShares Announces Inclusion of CXMT in China Semiconductor ETF
- Escalating U.S. Action Targets Chinese Data Center Tech Amid Heightened Security Concerns
- Critical Concerns Raised Over New Security Regulations on Robotics in Response to Ongoing Advances
- Shein Targets $40 Billion Valuation in Hong Kong IPO
- AsymBio Receives $184 Million Investment to Fuel Long-Term Growth
- Tesla’s China footprint complicates path to possible SpaceX merger
- China’s Methanol Revolution: A Success Story in Clean Transport Innovation
- 2026 China-U.S. Young Maker Competition Finals Conclude Successfully in Zhangjiang, Shanghai
- De Beers Group debuts Desert diamonds in Shanghai
- Tesla reports July deliveries of 93,579 units in China, up sharply from last year
Blogroll